Stocksigma LogoStocksigma Logo

Vista Pharma Board to Approve Q1 FY27 Results on 14 Aug '26

Vista Pharmaceuticals Ltd (BSE: 524711) has scheduled a Board of Directors meeting for 14 Aug '26. The key agenda item is the consideration and approval of

Vista Pharma Board to Approve Q1 FY27 Results on 14 Aug '26

Vista Pharmaceuticals Ltd 路 Intimation 路 14 Aug 2026, 5:30 am

Vista Pharma Board to Approve Q1 FY27 Results on 14 Aug '26 Vista Pharmaceuticals Ltd (BSE: 524711) has scheduled a Board of Directors meeting for 14 Aug '26. The key agenda item is the consideration and approval of the unaudited financial results for the first quarter ended 30 Jun '26. The board will also review the limited review report for the same period. This meeting will be crucial for assessing the company's performance at the start of the fiscal year.

Original exchange filing (PDF)

More announcements from Vista Pharmaceuticals Ltd

All Vista Pharmaceuticals Ltd announcements